Enamine Ltd. published the molecule of the week EN300-26866574

Enamine is a scientifically driven integrated drug discovery contract research organization (CRO). We maintain the world’s largest and most reputable collections of building blocks (over 350,000), screening compounds (over 4.7 million), and a vast database of synthetically feasible chemical structures — 𝐄𝐧𝐚𝐦𝐢𝐧𝐞 𝐑𝐄𝐀𝐋 𝐒𝐩𝐚𝐜𝐞. The company offers an extensive portfolio of expertly designed libraries for hit discovery, including Diversity, Fragment, Covalent, Bioactive, and Targeted Libraries, and delivers fully Integrated Discovery Services (IDD) spanning advanced organic synthesis, library synthesis, medicinal chemistry, high-throughput screening (HTS), and preclinical biology to support life sciences and pharmaceutical research worldwide.